258 related articles for article (PubMed ID: 26280900)
1. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
Saliba J; Saint-Martin C; Di Stefano A; Lenglet G; Marty C; Keren B; Pasquier F; Valle VD; Secardin L; Leroy G; Mahfoudhi E; Grosjean S; Droin N; Diop M; Dessen P; Charrier S; Palazzo A; Merlevede J; Meniane JC; Delaunay-Darivon C; Fuseau P; Isnard F; Casadevall N; Solary E; Debili N; Bernard OA; Raslova H; Najman A; Vainchenker W; Bellanné-Chantelot C; Plo I
Nat Genet; 2015 Oct; 47(10):1131-40. PubMed ID: 26280900
[TBL] [Abstract][Full Text] [Related]
2. Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.
Pegliasco J; Hirsch P; Marzac C; Isnard F; Meniane JC; Deswarte C; Pellet P; Lemaitre C; Leroy G; Rabadan Moraes G; Guermouche H; Schmaltz-Panneau B; Pasquier F; Colas C; Benusiglio PR; Bera O; Bourhis JH; Brissot E; Caron O; Chraibi S; Cony-Makhoul P; Delaunay-Darivon C; Lapusan S; de Fontbrune FS; Fuseau P; Najman A; Vainchenker W; Delhommeau F; Micol JB; Plo I; Bellanné-Chantelot C
Leukemia; 2022 Jan; 36(1):126-137. PubMed ID: 34172895
[TBL] [Abstract][Full Text] [Related]
3. Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32.
Babushok DV; Stanley NL; Morrissette JJD; Lieberman DB; Olson TS; Chou ST; Hexner EO
Leukemia; 2018 Dec; 32(12):2720-2723. PubMed ID: 30087419
[No Abstract] [Full Text] [Related]
4. Loss of
Sakai SS; Hasegawa A; Ishimura R; Tamura N; Kageyama S; Komatsu-Hirota S; Abe M; Ling Y; Okuda S; Funayama M; Kikkawa M; Miura Y; Sakimura K; Narita I; Waguri S; Shimizu R; Komatsu M
Mol Cell Biol; 2022 Jan; 42(1):e0002421. PubMed ID: 34748402
[TBL] [Abstract][Full Text] [Related]
5.
Pegliasco J; Schmaltz-Panneau B; Martin JE; Chraibi S; Khalife-Hachem S; Salviat F; Pasquier F; Willekens C; Lopez M; Ben-Ali A; Bera O; Caron O; Castilla-Llorent C; Cotteret S; Bourdin C; Saada V; Auger N; de Botton S; Vainchenker W; Fuseau P; Helias P; Benabdelali R; Marzac C; Meniane JC; Plo I; Bellanné-Chantelot C; Micol JB
Leuk Lymphoma; 2021 Jul; 62(7):1770-1773. PubMed ID: 33554699
[No Abstract] [Full Text] [Related]
6. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
Rumi E; Cazzola M
Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727
[TBL] [Abstract][Full Text] [Related]
7. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
[TBL] [Abstract][Full Text] [Related]
8. Germline ETV6 mutations and predisposition to hematological malignancies.
Feurstein S; Godley LA
Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
[TBL] [Abstract][Full Text] [Related]
9. ATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies.
Plo I; Bellanné-Chantelot C; Vainchenker W
Mol Cell Oncol; 2016 Mar; 3(2):e1094564. PubMed ID: 27308616
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.
Duployez N; Lejeune S; Renneville A; Preudhomme C
Expert Rev Hematol; 2016 Dec; 9(12):1189-1202. PubMed ID: 27819178
[TBL] [Abstract][Full Text] [Related]
11. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
[TBL] [Abstract][Full Text] [Related]
12. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
13. Expanding the role of the splicing USB1 gene from Poikiloderma with Neutropenia to acquired myeloid neoplasms.
Negri G; Crescenzi B; Colombo EA; Fontana L; Barba G; Arcioni F; Gervasini C; Mecucci C; Larizza L
Br J Haematol; 2015 Nov; 171(4):557-65. PubMed ID: 26306619
[TBL] [Abstract][Full Text] [Related]
14. [Role of ASXL1 mutation in myeloid malignancies].
Sheng MY; Zhou Y; Xu MJ; Yang FC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
[TBL] [Abstract][Full Text] [Related]
15. Germline genetic factors in the pathogenesis of myeloproliferative neoplasms.
Bellanné-Chantelot C; Rabadan Moraes G; Schmaltz-Panneau B; Marty C; Vainchenker W; Plo I
Blood Rev; 2020 Jul; 42():100710. PubMed ID: 32532454
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
[TBL] [Abstract][Full Text] [Related]
17. Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia.
Cardoso SR; Ryan G; Walne AJ; Ellison A; Lowe R; Tummala H; Rio-Machin A; Collopy L; Al Seraihi A; Wallis Y; Page P; Akiki S; Fitzgibbon J; Vulliamy T; Dokal I
Leukemia; 2016 Oct; 30(10):2083-2086. PubMed ID: 27133828
[No Abstract] [Full Text] [Related]
18. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
Czuchlewski DR; Peterson LC
Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
[TBL] [Abstract][Full Text] [Related]
19. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Rio-Machin A; Vulliamy T; Hug N; Walne A; Tawana K; Cardoso S; Ellison A; Pontikos N; Wang J; Tummala H; Al Seraihi AFH; Alnajar J; Bewicke-Copley F; Armes H; Barnett M; Bloor A; Bödör C; Bowen D; Fenaux P; Green A; Hallahan A; Hjorth-Hansen H; Hossain U; Killick S; Lawson S; Layton M; Male AM; Marsh J; Mehta P; Mous R; Nomdedéu JF; Owen C; Pavlu J; Payne EM; Protheroe RE; Preudhomme C; Pujol-Moix N; Renneville A; Russell N; Saggar A; Sciuccati G; Taussig D; Toze CL; Uyttebroeck A; Vandenberghe P; Schlegelberger B; Ripperger T; Steinemann D; Wu J; Mason J; Page P; Akiki S; Reay K; Cavenagh JD; Plagnol V; Caceres JF; Fitzgibbon J; Dokal I
Nat Commun; 2020 Feb; 11(1):1044. PubMed ID: 32098966
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies.
Tatwavedi D; Pellagatti A; Boultwood J
Adv Biol Regul; 2024 Jan; 91():100993. PubMed ID: 37827894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
